Mirae Asset Global Investments’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-493,431
| Closed | -$839K | – | 2361 |
|
|
2024
Q1 | $839K | Buy |
+493,431
| New | +$839K | ﹤0.01% | 1634 |
|
|
2023
Q4 | – | Sell |
-676,189
| Closed | -$406K | – | 2591 |
|
|
2023
Q3 | $406K | Buy |
676,189
+62,465
| +10% | +$37.5K | ﹤0.01% | 1989 |
|
|
2023
Q2 | $798K | Buy |
613,724
+88,444
| +17% | +$115K | ﹤0.01% | 1701 |
|
|
2023
Q1 | $924K | Buy |
525,280
+27,974
| +6% | +$49.2K | ﹤0.01% | 1583 |
|
|
2022
Q4 | $1.56M | Sell |
497,306
-138,488
| -22% | -$435K | ﹤0.01% | 1276 |
|
|
2022
Q3 | $3.12M | Buy |
635,794
+82,067
| +15% | +$402K | 0.01% | 964 |
|
|
2022
Q2 | $2.29M | Buy |
553,727
+169,334
| +44% | +$701K | 0.01% | 1106 |
|
|
2022
Q1 | $2.23M | Sell |
384,393
-70,884
| -16% | -$412K | ﹤0.01% | 1123 |
|
|
2021
Q4 | $3.42M | Buy |
455,277
+95,599
| +27% | +$717K | 0.01% | 980 |
|
|
2021
Q3 | $3.24M | Buy |
359,678
+56,576
| +19% | +$510K | 0.01% | 975 |
|
|
2021
Q2 | $3.63M | Buy |
303,102
+40,100
| +15% | +$480K | 0.01% | 903 |
|
|
2021
Q1 | $3.3M | Buy |
263,002
+119,168
| +83% | +$1.49M | 0.01% | 835 |
|
|
2020
Q4 | $2.24M | Buy |
143,834
+33,119
| +30% | +$517K | 0.01% | 883 |
|
|
2020
Q3 | $1.05M | Buy |
110,715
+35,747
| +48% | +$338K | 0.01% | 953 |
|
|
2020
Q2 | $672K | Buy |
74,968
+26,902
| +56% | +$241K | ﹤0.01% | 1046 |
|
|
2020
Q1 | $306K | Buy |
48,066
+5,257
| +12% | +$33.5K | ﹤0.01% | 1198 |
|
|
2019
Q4 | $358K | Buy |
42,809
+10,312
| +32% | +$86.2K | ﹤0.01% | 1314 |
|
|
2019
Q3 | $294K | Buy |
+32,497
| New | +$294K | ﹤0.01% | 1318 |
|